Publications

Case Reports
Journal Article Research Support, Non-U.S. Gov't
Ppublish 51 citations
Electronic publication date
June 9, 2009

View on Pubmed.gov 19297597 | View on doi.org 10.1128/JCM.016...

Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Search for publications in this journal J Clin Microbiol - 47(5):1556-8

Abstract

A patient with a clonal infection of Burkholderia pseudomallei had subpopulations with ceftazidime and amoxicillin-clavulanate susceptibilities that differed among the clinical specimens. Resistance was associated with a novel Cys69Tyr substitution in the Ambler class A beta-lactamase. Susceptibility testing of multiple colony variants from different sites should be performed for patients with culture-confirmed melioidosis.

References

J Clin Microbiol. 2007 Nov;45(11):3830-2

J Clin Microbiol. 2007 Feb;45(2):680-1

Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S145-51

Med Microbiol Immunol. 1999 Nov;188(2):91-7

Cited by 51 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.

Electronic publication date June 30, 2012

Search for publications in this journal PLoS One

Derek S Sarovich [...] David M Wagner et al.

Burkholderia pseudomallei is a gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and...

Journal Article Research Support, N.I.H., Extramural

Evolution of Burkholderia pseudomallei in recurrent melioidosis.

Electronic publication date September 15, 2012

Search for publications in this journal PLoS One

Hillary S Hayden [...] Michael A Jacobs et al.

Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with overwhelming septicemia leading to...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances